Celularity (CELU) Change in Taxes (2019 - 2020)
Celularity (CELU) posted quarterly Change in Taxes of -$52437.0 for Q4 2020, down 141.41% year-over-year from $126642.0 in Q1 2020, and down 132.2% quarter-over-quarter from -$22583.0 in Q3 2020.
Celularity (CELU) Change in Taxes (2019 - 2020) Analysis & Trends
Celularity (CELU) has reported Change in Taxes for 2 consecutive years, with -$52437.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Change in Taxes fell 141.41% year-over-year to -$52437.0; the TTM figure through Dec 2020 stood at $10381.0 (changed N/A YoY), while the FY2020 annual figure was $10381.0, down 45.02% from the prior year.
- Change in Taxes fell to -$52437.0 in Q4 2020 per CELU's latest filing, from -$22583.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $126642.0 in Q4 2019 and bottomed at -$224650.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -52,437.00 |
| Dec 31, 2020 | -52,437.00 |
| Sep 30, 2020 | -22,583.00 |
| Sep 30, 2020 | -22,583.00 |
| Jun 30, 2020 | 42,192.00 |
| Jun 30, 2020 | 42,192.00 |
| Mar 31, 2020 | 43,209.00 |
| Mar 31, 2020 | 43,209.00 |
| Dec 31, 2019 | 126,642.00 |
| Dec 31, 2019 | 126,642.00 |
| Sep 30, 2019 | -224,650.00 |
| Sep 30, 2019 | -224,650.00 |